Mivazerol prevents the tachycardia caused by emergence from halothane anesthesia partly through activation of spinal α2-adrenoceptors

Acta Anaesthesiologica Scandinavica

Volumn 42, Issue 2, 1998, Pages 238-245

  Guyaux, M ^a,b   Gobert, J ^a   Noyer, M ^a   Vandevelde, M ^a   Wulfert E ^a  

^a UCB PHARMA   (Belgium)

^b Pharmaceutical S ^*  (Belgium)

Author keywords

Cardiovascular; Emergence; Halothane; Mivazerol; Rats; Spinal; Sympathetic nervous system; 2 adrenoceptor agonists

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; HALOTHANE; MIVAZEROL; PERTUSSIS TOXIN; RAUWOLSCINE;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GENERAL ANESTHESIA; HEART RATE; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD; TACHYCARDIA;

EID: 0031890461     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1998.tb05116.x     Document Type: Article

References (28)

1. Mangano DT. Perioperative cardiac morbidity. Anesthesiology 1990: 72: 153-184.
2. Derbyshire DR, Smith G. Sympathoadrenal responses to anaesthesia and surgery. Br J Anaesth 1984: 56: 725-739.
3. Riles TS, Fisher FS, Schaeffer S, Pasternack PF, Baumann FG. Plasma catecholamine concentrations during abdominal aortic aneurysm surgery: The link to perioperative myocardial ischemia. Ann Vasc Surg 1993: 7: 213-219.
4. Udelsman R, Chrousos GP. Hormonal responses to surgical stress. Adv Exp Med Biol 1988: 245: 265-272.
5. Wood M. Effect of general anesthesia on modulation of sympathetic nervous system function. Adv Pharmacol 1994: 31: 449-458.
6. Mangano DT, Browner WS, Hollenberg M, London M, Tubau J, Tateo I. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. N Engl J Med 1990: 323: 1781-1788.
7. 2-adrenergic receptor agonists. U.S.P. 4923865, May 8, 1990.
8. 2-adrenergic receptors: Binding studies on different human and rat membrane preparations. Neurochem Int 1994: 24: 221-229.
9. 2-adrenoceptor agonist, following surgical stress in pentobarbital-anesthetized rats. FASEB J 1996: 10: A427.
10. 2-adrenergic stimulation with mivazerol on myocardial blood flow and function during coronary artery stenosis in anesthetized dogs. Anesth Analg 1996: 82: 702-711.
11. 2-adrenoceptor mediated sympathoinhibitory effects of mivazerol. Fundam Clin Pharmacol 1996: 10: 529-537.
12. Du XJ, Hoet B, Kharkevitch T, Riemersma RA. Mivazerol inhibits neuronal norepinephrine release during myocardial ischemia. J Mol Cell Cardiol 1992: 24: S 21.
13. 2-adrenergic agonist with anti-ischemic effects in animal models of myocardial ischemia. (Eur. Association of Cardiothoracic Anaesthesiologists, 7th Annual Meeting, Maastricht, June 9-12, 1992).
14. Riemersma RA, Debeer J-L. Effect of mivazerol on myocardial lactate production, blood flow and electrocardiographic signs of ischaemia induced by coronary artery ligation in the anaesthetized dog. Arzneim Forsch Drug Res 1997: 47: 10-13.
15. 2-adrenoceptor agonist, improves exercise induced ischemia in patients with angina pectoris. (Eur. Association of Cardiothoracic Anaesthesiologists, 7th Annual Meeting, Maastricht, June 9-12, 1992).
16. 2-adrenoceptor agonist mivazerol on hemodynamic stability and myocardial ischemia. Anesthesiology 1997: 86: 346-363.
17. Flacke JW. Alpha2-adrenergic agonists in cardiovascular anesthesia. J Cardiothor Vasc Anesth 1992: 6: 344-359.
18. Yaksh TL, Rudy TA. Chronic catheterisation of the spinal subarachnoïd space. Physiol Behav 1976: 17: 1031-1036.
19. Goto K, Longhurst PA, Cassis LA, Head RJ, Taylor DA, Rice PJ et al. Surgical sympathectomy of the heart in rodents and its effect on sensitivity to agonists. J Pharmacol Exp Ther 1985: 234: 280-287.
20. 2-adrenoceptor agonist, prevents tachycardia through activation of spinal and/or perispinal sites. (First European Congress of Pharmacology, Milan, Italy, June 16-19, 1995).
21. Langer SZ, Cavero I, Massingham R. Recent developments in noradrenergic neurotransmission and its relevance to the mechanism of action of antihypertensive agents. Hypertension 1980: 2: 372-382.
22. Limbird LE. Receptors linked to inhibition of adenylate cyclase: additional signaling mechanisms. FASEB J 1988: 2: 2686-2695.
23. Franz DN, Peterson RG, Madsen PW, Sangdee C. Enhancement of central transmission to sympathetic preganglionic neurons by phosphodiesterase inhibitors and its prevention by clonidine. J Auton Nerv Syst 1987: 19: 199-209.
24. 2 agonist binding sites in the rat and human central nervous system: analysis of sone functionnal, anatomic correlates of the pharmacological effects of clonidine and related adrenergic agents. Brain Res Rev 1984: 7: 69-101.
25. 2-adrenoceptors in the rat spinal cord and its modification after noradrenergic denervation: A quantitative autoradiographic study. J Neurosci Res 1994: 39: 319-329.
26. Guyenet PG, Cabot JH. Inhibition of sympathetic preganglionic neurons by catecholamines and clonidine: mediation by an α-adrenergic receptor. J Neurosci Res 1981: 1: 908-917.
27. Coote JH, MacLeod VH, Fleetwood-Walker S, Gilbey MP. The response of individual sympathetic preganglionic neurons to microphoretically applied endogenous monoamines. Brain Res 1981: 215: 135-145.
28. Kubo T, Nagura J, Misu Y. Pharmacological characterisation of spinal alpha-adrenoceptors related to blood pressure control in rats. J Pharmacol Exp Ther 1987: 240: 298-302.